Neil Johnson

  • Medical Director, Fertility Plus, National Women’s Health, Auckland, New Zealand
  • Gynaecologist and Fertility Sub-specialist, Repromed, Auckland, New Zealand
  • Honorary Professor, University of Adelaide, Australia
  • Honorary Clinical Academic, University of Auckland, New Zealand

Neil Johnson’s (MD CREI FRCOG FRANZCOG MRCGP) main research interests are in evidence based gynaecology and fertility treatments, the fertility aspects of endometriosis (for which he has pioneered the use of lipiodol in New Zealand) and polycystic ovary syndrome.

Neil has served on the board of Endometriosis New Zealand since 2004, and has been chairperson of the Royal Australian & New Zealand College of Obstetricians & Gynaecologists (RANZCOG) Reproductive Endocrinology & Infertility (REI) Subspecialty Training Committee since 2009. He has chaired the ACCEPT (Australasian CREI Consensus Expert Panel on Trial evidence) Group since its inception in 2008 and the multicentre clinical trials network REACT-ANZ (Reproduction And Clinical Trials – Australia and New Zealand) since 2006. He had the privilege of convening the Montpellier WES consensus on the management of endometriosis in 2011.

Neil Johnson was appointed to the board of the World Endometriosis Society in March 2008 and, having served as its Vice President from 2011-2014, was appointed President Elect in April 2014, and President in May 2017.